A novel biosensor platform for detecting lung cancer using urine samples showed high sensitivity and specificity in clinical ...

(Alliance News) - Avacta Group PLC on Monday revealed it has agreed to collaborate with AI-focused precision medicine business, Tempus AI Inc, to optimise its clinical development process and enable ...

A groundbreaking initiative by the Department of Energy and Microsoft is set to transform scientific computing through cloud ...

BioNTech's oncology assets, including BNT327/PM8002, show promising results. Read why I maintain my buy rating on BNTX stock.

Bertram Yuh, MD, MISM, MSHCPM, discussed how single-port robotic surgery has changed treatment paradigms for patients with ...

PARIS, Oct. 21, 2024 /PRNewswire/ -- Okomera announces Bpifrance funding to develop and standardize novel CRISPR screening assay to accelerate drug discovery in oncology with leading cancer research ...

The mRNA Revolution When the COVID-19 pandemic struck, the world's medical community initially prepared for a disaster of the scale of the Spanish Flu, which struck during WW1 and killed 50 million ...

BioNTech (BNTX) and OncoC4 have had a partial clinical hold placed by the FDA on a Phase 3 study for BNT316/ONC-392 in the ...

NANTES, France, October 17, 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced it will be presenting its ...

The global high potency API (HPAPI) contract manufacturing market achieved a market value of USD 8 billion in 2022 and is ...

Dr. Padungsutt said, "It's a privilege to take the helm of one of Thailand's best-regarded contract research organizations. I ...